FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

Companies Increasingly Using ‘Tattleware’

Employers have been turning to digital surveillance platforms…
FDA Authorizes Novavax COVID Vaccine

Protesters Take to the Streets in France for 9th Week

The streets of France were flooded for the ninth straight week…
FDA Authorizes Novavax COVID Vaccine

North Korea Tests New Cruise Missile

North Korea announced it tested a new cruise ballistic missile…